Cargando…
ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress
BACKGROUND AND PURPOSE: ShengMai-San (SMS) is traditionally used to treat ischemic cardiovascular and cerebrovascular diseases. Recently, several studies have reported the cardioprotective effects of SMS in diabetic animals. However, the potential mechanisms have not yet been fully elucidated. In th...
Autores principales: | Lu, Yanting, Zhu, Shu, Wang, Xiaoyan, Liu, Juhai, Li, Yingying, Wang, Wei, Wang, Shijun, Wang, Furong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884944/ https://www.ncbi.nlm.nih.gov/pubmed/33603429 http://dx.doi.org/10.2147/DMSO.S287582 |
Ejemplares similares
-
YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α
por: Zhao, Yichao, et al.
Publicado: (2016) -
Mechanism of new optimized Sheng-Mai-San Formula to regulate cardiomyocyte apoptosis through NMDAR pathway
por: Hou, Yazhu, et al.
Publicado: (2023) -
Cardioprotection by combination of three compounds from ShengMai preparations in mice with myocardial ischemia/reperfusion injury through AMPK activation-mediated mitochondrial fission
por: Li, Fang, et al.
Publicado: (2016) -
Protective Effects of Sheng-Mai-San on Right Ventricular Dysfunction during Chronic Intermittent Hypoxia in Mice
por: Chai, Cheng-Zhi, et al.
Publicado: (2016) -
Sheng Mai San protects H9C2 cells against hyperglycemia-induced apoptosis
por: Pang, Bing, et al.
Publicado: (2019)